DuPont posts lower profit, but beats Street
October 26, 2010 at 09:05 AM EDT
The company cites higher costs and the loss of patent protection for some of its pharmaceutical products for its bottom-line results.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.